Delray Beach, FL, Nov. 28, 2025 (GLOBE NEWSWIRE) — Rising CVD prevalence, rapid adoption of minimally invasive procedures, and strong innovation pipelines position the sector for sustained 7.3% CAGR growth. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=72205881 Expanding Market Drivers: Growing CVD Prevalence and Technology Adoption Market Restraints: Regulatory Complexity Remains a Barrier Opportunity Spotlight: Aging Population to Drive Device Demand Challenges: Complications Associated with Implantable Devices Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=72205881 Market Ecosystem & Segment Leadership Structural Heart Devices to Record Fastest Growth Hospitals & Clinics Lead End-User Demand North America Maintains Market Leadership Key Market Participants Recent Strategic Developments Why This Matters for Industry Leaders For more information, Inquire Now! Discover Connected Healthcare Market Opportunities: Get access to the latest updates on Top Companies in Cardiovascular Devices and Cardiovascular Devices Market Size
The global cardiovascular devices market, valued at US$72.83 billion in 2023, stood at US$77.71 billion in 2024 and is projected to advance at a resilient CAGR of 7.3% from 2024 to 2029, culminating in a forecasted valuation of US$110.39 billion by the end of the period. As healthcare systems worldwide pivot toward minimally invasive and technology-driven cardiac care, demand for advanced diagnostic, therapeutic, and monitoring devices continues to accelerate.
The cardiovascular devices market is directly fueled by the rise of diabetes, hypertension, obesity, and sedentary lifestyles, all of which significantly elevate CVD risk. As global populations age–particularly those above 65, projected to double by 2050–the need for advanced cardiac solutions intensifies.
Healthcare providers worldwide are increasingly turning to bioresorbable stents, drug-eluting stents, transcatheter valves, and next-generation imaging systems that enhance procedural efficacy and reduce recovery times. Patient preference for minimally invasive procedures and remote monitoring further accelerates adoption.
Strong government initiatives encouraging early diagnosis and treatment, coupled with rising healthcare expenditure in both developed and emerging economies, are shaping a conducive environment for growth.
Despite momentum, manufacturers face challenges navigating stringent regulatory frameworks. Lengthy approval timelines and extensive clinical evaluation requirements, while essential for patient safety, delay market entry and inflate operational costs–particularly for emerging innovators and smaller companies.
Where will the next wave of demand originate? The elderly population segment remains the single largest opportunity. Age-related conditions such as coronary artery disease, arrhythmias, heart failure, and valvular disorders necessitate advanced diagnostic and therapeutic devices.
Minimally invasive solutions–especially TAVR, mitral repair systems, and next-generation monitoring devices–are expected to witness strong uptake as healthcare systems expand geriatric capabilities and insurers broaden reimbursement coverage.
While implantable devices such as pacemakers, defibrillators, and stents are central to modern cardiology, complications including infections, clotting, allergic reactions, and device malfunctions remain concerns for clinicians and patients. These risks may limit widespread adoption and create additional cost burdens for hospitals and health systems.
Interventional Cardiology Dominates the Market
Interventional cardiology remains the largest segment, driven by the rising use of stents, catheters, balloons, and atherectomy systems in PCI procedures. Favorable reimbursement and strong clinical outcomes reinforce its leadership position.
The structural heart segment is set to register the highest CAGR, propelled by breakthroughs in TAVR, mitral valve repair, and tricuspid replacement systems, supported by early detection efforts and improved global clinical access.
Hospitals will continue to represent the largest end-user segment as they expand specialized cardiac centers, catheterization labs, and minimally invasive surgery programs.
North America holds the largest regional share due to high CVD incidence, mature healthcare infrastructure, advanced treatment adoption, strong R&D investments, and growing health-conscious behavior among patients.
Major companies shaping the global cardiovascular devices landscape include:
Boston Scientific Corporation, Medtronic, Abbott, B. Braun SE, Terumo Corporation, Edwards Lifesciences, Koninklijke Philips N.V., BIOTRONIK, GE Healthcare Technologies, Siemens Healthineers, Johnson & Johnson, Baxter International, Getinge AB, Lepu Medical, Nihon Kohden, MicroPort Scientific, Japan Lifeline, AngioDynamics, Artivion, Sahajanand Medical Technologies, W.L. Gore & Associates, among others.
For CEOs, CFOs, and strategic decision-makers, the accelerating cardiovascular devices market signals:
Interventional Cardiology Devices Market
Structural Heart Devices Market
Intracardiac Echocardiography Market
Cardiac Tissue Engineering Market
Vascular Stent Market
About MarketsandMarkets(TM):
MarketsandMarkets(TM) has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets(TM) is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore(TM), which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets(TM).com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets(TM) INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
